Information  X 
Enter a valid email address

Evgen Pharma PLC Ord 0.25P (EVG)

Date Time Source Announcement
24 Sep 2020 7:00 am
RNS
Appointment of Chief Executive Officer
15 Sep 2020 7:00 am
RNS
Licence agreement with Juvenescence
18 Aug 2020 3:30 pm
RNS
Holding(s) in Company
  3:25 pm
RNS
Holding(s) in Company
14 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
05 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
31 Jul 2020 3:40 pm
RNS
Holding(s) in Company
24 Jul 2020 9:47 am
RNS
Share option exercise and issue of equity
17 Jul 2020 12:05 pm
RNS
Holding(s) in Company
  12:02 pm
RNS
Holding(s) in Company
16 Jul 2020 2:52 pm
RNS
Result of AGM
07 Jul 2020 11:13 am
RNS
Share option exercise and issue of equity
06 Jul 2020 7:00 am
RNS
Share option exercise and issue of equity
23 Jun 2020 11:44 am
RNS
Holding(s) in Company
  11:38 am
RNS
Holding(s) in Company
19 Jun 2020 7:00 am
RNS
Notice of AGM
17 Jun 2020 9:38 am
RNS
Holding(s) in Company
  9:37 am
RNS
Holding(s) in Company
  7:00 am
RNS
SFX-01 to be evaluated in COVID-19 trial
15 Jun 2020 5:05 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Final Results
08 Jun 2020 7:00 am
RNS
Paper on SFX-01 in ER positive breast cancer
05 Jun 2020 7:00 am
RNS
Notice of Results
15 May 2020 12:30 pm
RNS
Statement Re: Share Price Movement
30 Apr 2020 7:00 am
RNS
Directorate Change
20 Feb 2020 9:27 am
RNS
Holding(s) in Company
13 Feb 2020 7:00 am
RNS
University of Rochester Collaboration
06 Feb 2020 7:00 am
RNS
University of Manchester collaboration discovery
29 Jan 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
20 Jan 2020 3:39 pm
RNS
Holding(s) in Company
17 Jan 2020 3:32 pm
RNS
Holding(s) in Company
08 Jan 2020 9:52 am
RNS
Holding(s) in Company
17 Dec 2019 7:01 am
RNS
Investor presentation
  7:00 am
RNS
Half-year Report
05 Dec 2019 7:00 am
RNS
MOU with The University of Dundee
04 Dec 2019 3:11 pm
RNS
Notice of Results
14 Nov 2019 11:59 am
RNS
Holding(s) in Company
11 Nov 2019 12:11 pm
RNS
SAS study clarification
  7:00 am
RNS
SFX-01 results in SAS study
30 Sep 2019 7:00 am
RNS
ESMO presentation of Phase II STEM clinical data
23 Sep 2019 7:00 am
RNS
Update on extended-use phase of STEM trial
05 Sep 2019 7:00 am
RNS
Agreement for supply of SFX-01 for autism trial
28 Aug 2019 7:00 am
RNS
Update on SAS study
07 Aug 2019 7:00 am
RNS
Grant of further European patent
05 Aug 2019 7:00 am
RNS
Research collaboration
25 Jul 2019 1:00 pm
RNS
Grant of Options
18 Jul 2019 3:47 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
24 Jun 2019 7:00 am
RNS
SFX-01 featured in SAH review paper
19 Jun 2019 10:39 am
RNS
Posting of Annual Report and AGM Notice
13 Jun 2019 7:00 am
RNS
Full Year Results
11 Jun 2019 7:00 am
RNS
Notification of Preliminary Results
22 May 2019 1:32 pm
RNS
Holding(s) in Company
21 May 2019 7:00 am
RNS
Share Option Exercise and Issue of Equity
09 May 2019 5:49 pm
RNS
Holding(s) in Company
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t